Meeting
2023 ASCO Genitourinary Cancers Symposium
DNA alterations in papillary renal cancer.
Authors
Francesca Jackson-Spence
Barts Cancer Institute, London, United Kingdom
Francesca Jackson-Spence , Charlotte Ackerman , Bernadett Szabados , Charlotte Toms , Agne Jovaisaite , Rachel Gunnell , Cristina Suárez , James Larkin , Poulam Patel , Begoña Pérez Valderrama , Alejo Rodriguez-Vida , Hilary Glen , Fiona C. Thistlethwaite , Christy Ralph , Gopalakrishnan Srinivasan , Maria Jose Mendez-Vidal , Aleksandra Markovets , Ryan James Hartmaier , Thomas Powles
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral and Testicular Cancers
Track
Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 725)
DOI
10.1200/JCO.2023.41.6_suppl.725
Abstract #
725
Poster Bd #
K20
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Distinct mutational landscapes characterize melanomas metastatic to different anatomical sites.
First Author: Mahesh Y. Iddawela
Poster
2021 ASCO Annual Meeting
Clinical activity of durvalumab and savolitinib in MET-driven, metastatic papillary renal cancer.
First Author: Cristina Suarez Rodriguez
Poster
2023 ASCO Annual Meeting
Comprehensive characterization of androgen receptor expression in breast cancer.
First Author: Priya Jayachandran
Poster
2022 ASCO Annual Meeting
HER2 in uterine carcinosarcoma: Testing platforms and implications for targeted therapy.
First Author: Navin Maredia